Evofem Biosciences Successfully Amends S.P.A. with Institutional Investor
- Monday, September 11, 2023, 7:00
- Finance
- Add a comment
— Investor withdraws March 2023 Notice of Default — — Notes are no longer convertible to shares of common stock, removing potential dilution from the previously-reserved over 240 million shares of common stock — — Evofem may repurchase Notes within five years for as little as $14…
About the Author
adminasapcorp has written 39016 stories on this site.